LSD molecule:

Image from PubChem

LSD Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Assess the Abuse Potential of the Hydrocodone Bitartrate Extended-Release Tablet in Healthy, Nondependent, Recreational Opioid Users

To see complete record on, please visit this link

Id: NCT01596673

Organisation Name: Teva Branded Pharmaceutical Products R&D, Inc.

Overal Status: Completed

Start Date: March 2012

Last Update: November 21, 2012

Lead Sponsor: Cephalon

Brief Summary: The purpose of this study is to assess the relative abuse potential of the hydrocodone bitartrate extended-release tablet compared to immediate-release hydrocodone bitartrate.

  • Drug Abuse

Total execution time in seconds: 0.46970891952515